COVID-19 Vaccines in Children
- PMID: 38202094
- PMCID: PMC10779890
- DOI: 10.3390/jcm13010087
COVID-19 Vaccines in Children
Abstract
The COVID-19 pandemic has left an indelible mark on global health, affecting individuals of all ages across diverse communities. While the virus has predominantly been associated with severe outcomes in adults, its impact on children has garnered increasing attention. Today, three COVID-19 vaccines are available for use in the U.S. and recommended by the Advisory Committee on Immunization Practices (ACIP). As of September 2023, ongoing genomic surveillance identified SARS-CoV-2 XBB sublineages as the most common circulating SARS-CoV-2 variants, constituting over 99% of sequenced SARS-CoV-2 specimens in the US. Recently, recommendations for COVID-19 vaccination were updated accordingly to the 2023-2024 Omicron-XBB.1.5-adapted monovalent COVID-19 vaccine to provide heightened protection against currently circulating SARS-CoV-2 XBB-sublineage variants. COVID-19 vaccines have proven to be safe, efficacious, and effective at protecting against COVID-19 and preventing severe illness in children and adolescents.
Keywords: COVID-19; COVID-19 in children; COVID-19 vaccines; pediatric COVID-19.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Centers for Disease Control and Prevention COVID Data Tracker. [(accessed on 7 September 2023)]; Available online: https://covid.cdc.gov/covid-data-tracker/#datatracker-home.
-
- Anderson E.J., Campbell J.D., Creech C.B., Frenck R., Kamidani S., Munoz F.M., Nachman S., Spearman P. Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral? Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2021;73:336–340. doi: 10.1093/cid/ciaa1425. - DOI - PMC - PubMed
-
- Siegel D.A., Reses H.E., Cool A.J., Shapiro C.N., Hsu J., Boehmer T.K., Cornwell C.R., Gray E.B., Henley S.J., Lochner K., et al. Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0–17 Years—United States, August 2020–August 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1249–1254. doi: 10.15585/mmwr.mm7036e1. - DOI - PMC - PubMed
-
- Delahoy M.J., Ujamaa D., Whitaker M., O’Halloran A., Anglin O., Burns E., Cummings C., Holstein R., Kambhampati A.K., Milucky J., et al. Hospitalizations Associated with COVID-19 among Children and Adolescents—COVID-NET, 14 States1 March 2020–14 August 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1255–1260. doi: 10.15585/mmwr.mm7036e2. - DOI - PMC - PubMed
-
- Marks K.J., Whitaker M., Anglin O., Milucky J., Patel K., Pham H., Chai S.J., Kirley P.D., Armistead I., McLafferty S., et al. Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19—COVID-NET, 14 States, July 2021–January 2022. MMWR Morb. Mortal. Wkly. Rep. 2022;71:271–278. doi: 10.15585/mmwr.mm7107e4. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
